Clinical Trial Update: Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether statins prevent doxorubicin-induced cardiovascular toxicity in patients with breast cancer or lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphoma

Drugs mentioned

• Statins

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Cancer, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2022-01-04